Dietary Butyrate Helps to Restore the Intestinal Status of a Marine Teleost (Sparus aurata) Fed Extreme Diets Low in Fish Meal and Fish Oil

PLoS One. 2016 Nov 29;11(11):e0166564. doi: 10.1371/journal.pone.0166564. eCollection 2016.

Abstract

There is a constant need to find feed additives that improve health and nutrition of farmed fish and lessen the intestinal inflammation induced by plant-based ingredients. The objective of this study was to evaluate the effects of adding an organic acid salt to alleviate some of the detrimental effects of extreme plant-ingredient substitution of fish meal (FM) and fish oil (FO) in gilthead sea bream diet. Three experiments were conducted. In a first trial (T1), the best dose (0.4%) of sodium butyrate (BP-70 ®NOREL) was chosen after a short (9-weeks) feeding period. In a second longer trial (T2) (8 months), four diets were used: a control diet containing 25% FM (T2-D1) and three experimental diets containing 5% FM (T2-D2, T2-D3, T2-D4). FO was the only added oil in D1, while a blend of plant oils replaced 58% and 84% of FO in T2-D2, and T2-D3 and T2-D4, respectively. The latter was supplemented with 0.4% BP-70. In a third trial (T3), two groups of fish were fed for 12 and 38 months with D1, D3 and D4 diets of T2. The effects of dietary changes were studied using histochemical, immunohistochemical, molecular and electrophysiological tools. The extreme diet (T2-D3) modified significantly the transcriptomic profile, especially at the anterior intestine, up-regulating the expression of inflammatory markers, in coincidence with a higher presence of granulocytes and lymphocytes in the submucosa, and changing genes involved in antioxidant defences, epithelial permeability and mucus production. Trans-epithelial electrical resistance (Rt) was also decreased (T3-D3). Most of these modifications were returned to control values with the addition of BP-70. None of the experimental diets modified the staining pattern of PCNA, FABP2 or ALPI. These results further confirm the potential of this additive to improve or reverse the detrimental effects of extreme fish diet formulations.

MeSH terms

  • Alkaline Phosphatase / metabolism
  • Animals
  • Butyric Acid / pharmacology*
  • Dietary Fats, Unsaturated / pharmacology*
  • Electrophysiological Phenomena / drug effects
  • Fatty Acid-Binding Proteins / metabolism
  • Fish Oils / chemistry*
  • Intestinal Mucosa / metabolism*
  • Intestines / drug effects*
  • Proliferating Cell Nuclear Antigen / metabolism
  • Sea Bream / genetics
  • Sea Bream / growth & development
  • Sea Bream / metabolism*
  • Sea Bream / physiology
  • Transcriptome / drug effects

Substances

  • Dietary Fats, Unsaturated
  • Fatty Acid-Binding Proteins
  • Fish Oils
  • Proliferating Cell Nuclear Antigen
  • Butyric Acid
  • Alkaline Phosphatase

Grants and funding

This work has been carried out with financial support from the European Commission of the European Union, specific RTD Framework Programme 7, (FP7/2007-2013) under grant projects ARRAINA (KBBE-2011-288925) to JPS, AO and VK, AQUAEXCEL (262336) under TNA project 0044/03/04/14a to FG, and AQUAEXCEL2020 (652831) under TNA project 0004/01-INTEBREAM to JF. This publication reflects the views only of the authors, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. JF was also funded by the Portuguese Foundation for Science and Technology (FCT) through Project PTDC/MARBIO/3034/2014. CCMar was supported by national funds from FCT through institutional project UID/Multi/04326/2013. Additional funding has been received by Spanish Ministry of Economy and Competitiveness (MINECO) project no. AGL2013-48560-R to JPS and ASB, and Generalitat Valenciana (PROMETEOII/2014/085) to ASB. JAMS received a Postdoctoral Research Fellow (Juan de la Cierva-Formación, Reference FJCI-2014-20161) from MINECO.